Vaxxas announced today the Australian government is granting it nearly $5.5 million for the manufacturing of its vaccine delivery device.
Cambridge, Massachusetts-based Vaxxas picked up AU$8.2 million ($5.48 million). The second-round grant represents part of the Australian government’s Modern Manufacturing Initiative (MMI). Funding supports the manufacturing scale-up of Vaxxas’ device for applying vaccines to the skin using a small patch.
Get the full story at our sister site, Drug Delivery Business News.